article thumbnail

Synthesised sea sponge molecule could fight Parkinson’s

Drug Discovery World

Organic chemists at t he University of California, Los Angeles (UCLA) have created the first synthetic version of a molecule recently discovered in a sea sponge that may have therapeutic benefits for Parkinson’s disease and similar disorders.

article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

She is currently the CEO of Twentyeight-Seven, a biotech company focused on novel RNA biology that she co-founded alongside prominent Harvard investigators. Lisa is a senior pharmaceutical executive with more than 20 years of experience in research and drug discovery. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley.